BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹75 Cr | ₹5,999,757 Cr | ₹0.00 Cr | ₹43 Cr | ₹25 Cr |
What is the latest Operating Profit of BETA DRUGS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹75 Cr |
| Mar2025 | ₹5,999,757 Cr |
| Mar2024 | ₹0.00 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹25 Cr |
How is Operating Profit of BETA DRUGS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹75 Cr | -100.00 | |
| Mar2025 | ₹5,999,757 Cr | 599,975,652,400.00 | |
| Mar2024 | ₹0.00 Cr | -100.00 | |
| Mar2023 | ₹43 Cr | 72.57 | |
| Mar2022 | ₹25 Cr | - | |
Compare Operating Profit of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,004.5 Cr | 1.7% | -9.3% | -0.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 1.7% |
-9.3% |
-0.8% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses